Liabilities / Assets
59th percentile
Higher debt load relative to assets than 59% of similar nonprofits.
Pharmacotherapy Publications Inc
990 • Fiscal year 2012 • EIN 04-2720360
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.11x
Liabilities / Revenue
74th percentile
Higher debt load relative to revenue than 74% of similar nonprofits.
Net Margin
4th percentile
Higher net margin than 4% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
11th percentile
Faster asset growth than 11% of similar nonprofits.
Revenue Growth
Score unavailable
No earlier valid filing was available within the previous three public years.
Balance Sheet
Assets
Down$892,073
Down $190,501 (-18%) from 2011
Net Assets
Down$793,090
Down $240,854 (-23%) from 2011
Liabilities
Up$98,983
Up $50,353 (+104%) from 2011
Revenue And Expenses
Revenue
$421,035
No earlier filing loaded for comparison.
Expenses
Down$701,815
Down $301,070 (-30%) from 2011
Net Income
-$280,780
No earlier filing loaded for comparison.
Historical Trend
Filing Detail Status
This 2012 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2012 to Dec 31, 2012
Mission and Program Overview
Mission
The organization's primary mission is to serve subscribers and the general public with education, review and publication of research and study results of drugs and the interaction of pharmaceuticals.
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2012 • Form 990Summary only. Only limited summary data is available for this year.
- Assets
- $892,073
- Liabilities
- $98,983
- Net assets
- $793,090
- Revenue
- $421,035
- Expenses
- $701,815
- Net income
- -$280,780